Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Science Translational Medicine|August 2, 2023
Single-cell transcriptomics identifies prothymosin α restriction of HIV-1 in vivoAviva Geretz, Philip K Ehrenberg, Robert J Clifford, et al.
The Lancet. HIV|February 10, 2020
Late boosting of the RV144 regimen with AIDSVAX B/E and ALVAC-HIV in HIV-uninfected Thai volunteers: a double-blind, randomised controlled trialPunnee Pitisuttithum, Sorachai Nitayaphan, Suwat Chariyalertsak, et al.
Med (New York, N.Y.)|July 23, 2022
Acute HIV-1 infection viremia associate with rebound upon treatment interruptionThembi Mdluli, Yifan Li, Suteeraporn Pinyakorn, et al.
Nature Communications|May 9, 2024
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody bindingHongjun Bai, Eric Lewitus, Yifan Li, et al.
The Journal of Clinical Investigation|September 21, 2023
Initial productive and latent HIV infections originate in vivo by infection of resting T cellsStephen W Wietgrefe, Jodi Anderson, Lijie Duan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 11, 2020
Central Nervous System Safety During Brief Analytic Treatment Interruption of Antiretroviral Therapy Within 4 Human Immunodeficiency Virus Remission Trials: An Observational Study in Acutely Treated People Living With Human Immunodeficiency VirusJoanna Hellmuth, Camilla Muccini, Donn J Colby, et al.
The Journal of Infectious Diseases|March 23, 2017
Randomized, Double-Blind Evaluation of Late Boost Strategies for HIV-Uninfected Vaccine Recipients in the RV144 HIV Vaccine Efficacy TrialSupachai Rerks-Ngarm, Punnee Pitisuttithum, Jean-Louis Excler, et al.
Pageof 13